BioScrip Announces Additions to Senior Leadership Team
28 Novembre 2017 - 2:00PM
BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), the
largest independent national provider of infusion and home care
management solutions, today announced the appointments of Harriet
Booker as Senior Vice President, Chief Operating Officer and Danny
R. Claycomb as Senior Vice President, Revenue Cycle Management. The
appointments are effective November 28, 2017 and November 27, 2017,
respectively.
Ms. Booker brings vast leadership experience in
the home infusion industry to BioScrip. For over two decades,
she has worked in executive leadership roles for Option Care, its
predecessor company Walgreens-Option Care, Coram/CVS Specialty
Infusion Services, Coram Specialty Infusion, and Apria Healthcare.
Most recently, in 2016, she served as Interim Senior Vice
President, Revenue Cycle Management for Option Care. Prior to that,
and for seven years, Ms. Booker successfully led Sales and
Marketing for Coram/CVS Specialty Infusion Services, including
roles as Executive Vice President of Sales and Chief Commercial
Officer, among others. She served in leadership roles for Option
Care (and Walgreens-Option Care) from 2002-2008 including Director
of Sales Operations, Vice President of Managed Care Sales, and Vice
President of Sales and Marketing. Her home infusion experience also
includes pertinent work in patient admissions, revenue cycle
management, financial planning, forecasting, pricing, and
contracting.
Mr. Claycomb joins BioScrip with extensive
operational financial leadership experience, including seventeen
years in the healthcare industry at Envision Healthcare, Coram/CVS
Specialty Infusion Services, Coram Specialty Infusion, and
Medtronic. Prior to joining BioScrip, Mr. Claycomb most recently
served as Senior Vice President, Revenue Cycle Management at
Envision Healthcare. Previously, Mr. Claycomb served as Senior Vice
President, Revenue Cycle Management at Coram/CVS Specialty Infusion
Services, from 2005 to 2015. Mr. Claycomb also served in various
leadership roles at Medtronic from 2000 to 2005.
“On behalf of our board and management team, I
am excited to welcome Harriet and Danny to BioScrip,” said Daniel
E. Greenleaf, President and Chief Executive Officer. “Harriet and
Danny each have extensive industry experience in both public and
privately held healthcare companies, and a proven track record of
driving profitable growth, achieving targeted metrics, and
motivating strong team performance.”
About BioScrip, Inc.
BioScrip, Inc. is the largest independent
national provider of infusion and home care management solutions,
with approximately 2,200 teammates and nearly 80 service locations
across the U.S. BioScrip partners with physicians, hospital
systems, payors, pharmaceutical manufacturers and skilled nursing
facilities to provide patients access to post-acute care services.
BioScrip operates with a commitment to bring customer-focused
pharmacy and related healthcare infusion therapy services into the
home or alternate-site setting. By collaborating with the full
spectrum of healthcare professionals and the patient, BioScrip
provides cost-effective care that is driven by clinical excellence,
customer service, and values that promote positive outcomes and an
enhanced quality of life for those it serves.
Investor Contacts:
Stephen Deitsch |
|
|
David Clair |
Chief Financial Officer
& Treasurer |
|
|
ICR, Inc. |
T: (720)
697-5200 |
|
|
T: (646)
277-1266 |
stephen.deitsch@bioscrip.com |
|
|
david.clair@icrinc.com |
BioPlus Acquisition (NASDAQ:BIOS)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
BioPlus Acquisition (NASDAQ:BIOS)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024